Date:
January 4, 2012
Title:
Feature article in Cancer Research Technology about CCR4 CCR4 - from target discovery to a license and sponsored collaboration with Affitech
Under funding from Cancer Research UK, researchers in Affitech collaboration partner Professor Frances Balkwill’s lab at Barts Cancer Institute/ Queen Mary University of London, made the fortuitous and surprising discovery that the chemokine receptor CCR4 was over-expressed in tissue from some cervical cancer patients.
Read the full article through this link: